222 related articles for article (PubMed ID: 30350374)
1. Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma.
Suzuki Y; Maekawa S; Komatsu N; Sato M; Tatsumi A; Miura M; Matsuda S; Muraoka M; Nakakuki N; Shindo H; Amemiya F; Takano S; Fukasawa M; Nakayama Y; Yamaguchi T; Inoue T; Sato T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
Hepatol Res; 2019 Jan; 49(1):51-63. PubMed ID: 30350374
[TBL] [Abstract][Full Text] [Related]
2. Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma.
Wu JW; Kao JH; Tseng TC
Clin Mol Hepatol; 2021 Oct; 27(4):524-534. PubMed ID: 33618507
[TBL] [Abstract][Full Text] [Related]
3. Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy.
Cheung KS; Seto WK; Wong DK; Lai CL; Yuen MF
J Viral Hepat; 2017 Aug; 24(8):654-661. PubMed ID: 28185363
[TBL] [Abstract][Full Text] [Related]
4. HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
J Hepatol; 2016 Jul; 65(1):48-56. PubMed ID: 27034253
[TBL] [Abstract][Full Text] [Related]
5. Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.
Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
Aliment Pharmacol Ther; 2018 Jan; 47(1):43-54. PubMed ID: 29035003
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α.
Caviglia GP; Abate ML; Noviello D; Olivero A; Rosso C; Troshina G; Ciancio A; Rizzetto M; Saracco GM; Smedile A
Hepatol Res; 2017 Jul; 47(8):747-754. PubMed ID: 27577976
[TBL] [Abstract][Full Text] [Related]
7. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.
Maasoumy B; Wiegand SB; Jaroszewicz J; Bremer B; Lehmann P; Deterding K; Taranta A; Manns MP; Wedemeyer H; Glebe D; Cornberg M
Clin Microbiol Infect; 2015 Jun; 21(6):606.e1-10. PubMed ID: 25700889
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues.
Hosaka T; Suzuki F; Kobayashi M; Fujiyama S; Kawamura Y; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
Aliment Pharmacol Ther; 2019 Feb; 49(4):457-471. PubMed ID: 30663078
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature.
Afifi AM; Elgenidy A; Hashim M; Awad AK; Jalal PK
Rev Med Virol; 2022 Nov; 32(6):e2353. PubMed ID: 35441759
[TBL] [Abstract][Full Text] [Related]
11. Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B.
Seto WK; Wong DK; Fung J; Huang FY; Liu KS; Lai CL; Yuen MF
Clin Microbiol Infect; 2014 Nov; 20(11):1173-80. PubMed ID: 24975365
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Hepatitis B Core-Related Antigen (HBcrAg) During the Natural History of Hepatitis B Virus Infection.
Gou Y; Zhao Y; Rao C; Feng S; Wang T; Li D; Tao C
Clin Lab; 2017 Jul; 63(7):1063-1070. PubMed ID: 28792701
[TBL] [Abstract][Full Text] [Related]
13. HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues.
Wang B; Carey I; Bruce M; Montague S; Dusheiko G; Agarwal K
J Viral Hepat; 2018 Aug; 25(8):886-893. PubMed ID: 29532589
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells.
Aggarwal A; Odorizzi PM; Brodbeck J; van Buuren N; Moon C; Chang S; Adona M; Suthram S; Suri V; Trowe T; Turner S; Marcellin P; Buti M; Gaggar A; Fletcher SP; Diehl L; Feierbach B; Balsitis S
JHEP Rep; 2023 Apr; 5(4):100664. PubMed ID: 36908748
[TBL] [Abstract][Full Text] [Related]
15. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
Wang L; Cao X; Wang Z; Gao Y; Deng J; Liu X; Zhuang H
J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy.
Liao H; Liu Y; Li X; Wang J; Chen X; Zou J; Li Q; Liu L; Wang J; Huang B; Lu F; Xu D
Antivir Ther; 2019; 24(2):105-115. PubMed ID: 30511941
[TBL] [Abstract][Full Text] [Related]
17. Potential of ultra-highly sensitive immunoassays for hepatitis B surface and core-related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Suzuki F; Hosaka T; Imaizumi M; Kobayashi M; Ohue C; Suzuki Y; Fujiyama S; Kawamura Y; Sezaki H; Akuta N; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
Hepatol Res; 2021 Apr; 51(4):426-435. PubMed ID: 33270344
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of hepatitis B core-related antigen in chronic hepatitis B and hepatocellular carcinoma patients.
Chen S; Jia J; Gao Y; Li H; Fang M; Feng H; Guan W; Ji J; Gao Z; Gao C
Clin Chim Acta; 2018 Nov; 486():237-244. PubMed ID: 30025756
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation.
Suzuki T; Inoue T; Matsuura K; Kusumoto S; Hagiwara S; Ogawa S; Yagi S; Kaneko A; Fujiwara K; Watanabe T; Aoyagi K; Urata Y; Tamori A; Kataoka H; Tanaka Y
J Gastroenterol; 2022 Jul; 57(7):486-494. PubMed ID: 35478052
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers.
Tada T; Kumada T; Toyoda H; Kobayashi N; Akita T; Tanaka J
J Gastroenterol Hepatol; 2018 Apr; 33(4):918-925. PubMed ID: 28914957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
